Back
Piedmont Lithium Vs. Viking Therapeutics Industry Stock Comparison
Buy
63
PLL
Piedmont Lithium
Last Price:
13.41
Seasonality Move:
7.79%
Buy
61
VKTX
Viking Therapeutics
Last Price:
72.89
Seasonality Move:
35.84%
Buy
63
Piedmont Lithium (PLL)
is a Buy
Is Piedmont Lithium a Buy, Sell or Hold?
- The current Piedmont Lithium [PLL] share price is $13.43. The Score for PLL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- PLL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $72.88. The Score for VKTX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLL Stock Price Chart
What is Piedmont Lithium's stock price today?
-
The Piedmont Lithium share price today is $13.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLL is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $72.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
PLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 58.59 | Buy |
| Chaikin Money Flow: | -580091 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.48 - 13.78) | Buy |
| Bollinger Bands (100): | (8 - 12) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.7 | Buy |
| Relative Strength Index (14 RSI): | 58.87 | Buy |
| Chaikin Money Flow: | -2173078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.93 - 71.45) | Buy |
| Bollinger Bands (100): | (52.76 - 66.5) | Buy |
PLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.78 | Buy |
| 20-day SMA: | 12.81 | Buy |
| 50-day SMA: | 9.99 | Buy |
| 200-day SMA: | 11.9 | Buy |
| 8-day EMA: | 12.95 | Buy |
| 20-day EMA: | 12.23 | Buy |
| 50-day EMA: | 11 | Buy |
| 200-day EMA: | 14.97 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.08 | Buy |
| 20-day SMA: | 67.57 | Buy |
| 50-day SMA: | 64.45 | Buy |
| 200-day SMA: | 59.6 | Buy |
| 8-day EMA: | 71.57 | Buy |
| 20-day EMA: | 68.66 | Buy |
| 50-day EMA: | 65.15 | Buy |
| 200-day EMA: | 55.25 | Buy |
Piedmont Lithium Earnings Growth & PLL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.27 per share, and an increase next year of $1.55 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Piedmont Lithium Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||